Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis | BMC Immunology | Full Text

Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis | BMC Immunology | Full Text

Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) and immunosuppressive therapy (IST) are two major competing treatment strategies for acquired aplastic anemia (AA). Whether allo-HSCT is superior ...

Authors:Yangmin Zhu, Qingyan Gao, Jing Hu, Xu Liu, Dongrui Guan and Fengkui Zhang

Citation:BMC Immunology 2020 21:10

Content type:Research article

Published on: 6 March 2020

• ViewFull Text
 
• ViewPDF